Acute Wound Care Market by Product (Dressings (Foam, Hydrocolloid, Film), Devices (NPWT, Electric Stimulation, Oxygen & Hyberbaric Oxygen, Pressure Relief)), Wound Type (Surgical, Burns), End User (Hospitals, Clinics), & Region - Global Forecast to 2027
The global acute wound care market size is projected to reach USD 10,457.8 million by 2027 from USD 8,452.4 million in 2022, at a CAGR of 4.3% during the forecast period. The market is driven by factors such as the growing number of surgical procedures, growing incidence of burn injuries, and growing geriatric patient pool. Emerging economies such as China and Japan are providing lucrative opportunities for the players operating in the acute wound care market.
To know about the assumptions considered for the study, Request for Free Sample Report
The advanced wound care products accounted for the largest market share in the acute wound care market during the forecast period, by product”
The acute wound care market is segmented into advanced wound care products, surgical wound care products, and traditional wound care products. The advanced wound care products segment dominated the acute wound care market in 2021. This can be attributed to the rising burn incidences, increasing burden of surgical & traumatic wounds, and various advantages of advanced wound care products.
“In 2021, surgical & traumatic wounds segment accounted for the largest market share”
Based on wound type, the acute wound care market is segmented into surgical & traumatic wounds and, burns & other wounds. The surgical & traumatic wounds segment accounted for the largest market share in 2021. The rising number of surgical site infections (SSIs) is the major driver for this segment. Surgical wounds majorly occur due to SSIs. Thus, the rising incidence of surgical site infections is predicted to boost segment growth.
“The Asia Pacific market is expected to grow at the highest CAGR during the forecast period”
The global acute wound care market is segmented into five regions - North America, Europe, the Asia Pacific, Latin America, and the Middle East & Africa. The Asia Pacific region is expected to witness the highest growth in the acute wound care market during the forecast period. The high growth in this region can primarily be attributed to the rising healthcare spending, growing per capita income, the expansion of private-sector hospitals to rural areas in various APAC countries, increasing medical tourism, and the presence of high-growth markets. The low labor costs and favorable regulatory environment in the region are also expected to propel market growth. Additionally, the rising geriatric population in this region is expected to raise the demand for acute wound care products.
To know about the assumptions considered for the study, download the pdf brochure
The primary interviews conducted for this report can be categorized as follows:
- By Company Type: Tier 1 - 40%, Tier 2 - 30%, and Tier 3 - 30%
- By Designation: C-level - 27%, D-level - 18%, and Others - 55%
- By Region: North America - 51%, Europe - 21%, Asia Pacific - 18%, Latin America – 6% , and the Middle East & Africa – 4%
Lits of Companies Profiled in the Report:
- 3M (US)
- Coloplast A/S (Denmark)
- Medtronic (Ireland)
- Smith & Nephew (UK)
- Convatec Group Plc (UK)
- Medline Industries (US)
- Integra Lifesciences (US)
- Johnson & Johnson (US)
- Molnlycke Health Care Ab (Sweden)
- Baxter International (US)
- B. Braun (Germany)
- Paul Hartmann AG (Germany)
To speak to our analyst for a discussion on the above findings, click Speak to Analyst
TABLE OF CONTENTS
1 INTRODUCTION
1.1 OBJECTIVES OF THE STUDY
1.2 MARKET DEFINITION
1.2.1 INCLUSIONS & EXCLUSIONS OF THE STUDY
1.2.2 MARKETS COVERED
1.2.3 YEARS CONSIDERED FOR THE STUDY
1.3 CURRENCY
1.4 LIMITATIONS
1.5 STAKEHOLDERS
1.6 SUMMARY OF CHANGES
2 RESEARCH METHODOLOGY
2.1 RESEARCH DATA
2.2 RESEARCH APPROACH
2.2.1 SECONDARY DATA
2.2.1.1 Key data from secondary sources
2.2.2 PRIMARY DATA
2.2.2.1 Key data from primary sources
2.2.2.2 Key industry insights
2.3 MARKET SIZE ESTIMATION
2.3.1 BOTTOM-UP APPROACH
2.3.2 TOP-DOWN APPROACH
2.4 MARKET BREAKDOWN & DATA TRIANGULATION
2.5 ASSUMPTIONS FOR THE STUDY
2.6 GROWTH RATE ASSUMPTIONS
2.7 LIMITATIONS
2.8 RISK ASSESSMENT
3 EXECUTIVE SUMMARY
4 PREMIUM INSIGHTS
5 MARKET OVERVIEW
5.1 INTRODUCTION
5.2 MARKET DYNAMICS
5.2.1 DRIVERS
5.2.1.1 Increasing number of surgical procedures worldwide
5.2.1.2 Rising cases of traumatic injuries
5.2.1.3 Increasing number of burn injuries
5.2.1.4 Growing geriatric population
5.2.1.5 Rising technological advancements in acute wound care
5.2.2 RESTRAINTS
5.2.2.1 High cost of advanced wound care products
5.2.2.2 Stringent regulations for wound care dressings
5.2.3 OPPORTUNITIES
5.2.3.1 Growth potential of emerging countries
5.3 PRICING ANALYSIS
5.4 PATENT ANALYSIS
5.5 TRADE ANALYSIS
5.6 VALUE CHAIN ANALYSIS
5.7 SUPPLY CHAIN ANALYSIS
6 GLOBAL ACUTE WOUND CARE MARKET, BY PRODUCT (USD MILLION)
6.1 INTRODUCTION
6.2 ADVANCED WOUND CARE PRODUCTS
6.2.1 ADVANCED WOUND CARE DRESSINGS
6.2.1.1 FOAM DRESSINGS
6.2.1.2 HYDROCOLLOID DRESSINGS
6.2.1.3 FILM DRESSINGS
6.2.1.4 ALGINATE DRESSINGS
6.2.1.5 HYDROGEL DRESSINGS
6.2.1.6 COLLAGEN DRESSINGS
6.2.1.7 ALGINATE DRESSINGS
6.2.1.8 OTHER ADVANCED WOUND CARE DRESSINGS
6.2.2 WOUND THERAPY DEVICES
6.2.2.1 PORTABLE & CONVENTIONAL NPWT DEVICES
6.2.2.2 OXYGEN AND HYPERBARIC OXYGEN EQUIPMENTS
6.2.2.3 ELECTRIC STIMULATION DEVICES
6.2.2.4 PRESSURE RELIEF DEVICES
6.2.2.5 OTHER WOUND THERAPY DEVICES
6.2.3 TOPICAL AGENTS
6.3 SURGICAL WOUND CARE PRODUCTS
6.3.1 SUTURES
6.3.2 STAPLERS
6.3.3 TISSUE ADHESIVES, SEALANTS, AND GLUES
6.4 TRADITIONAL WOUND CARE PRODUCTS
6.4.1 MEDICAL TAPES
6.4.2 DRESSINGS
6.4.3 CLEANSING AGENTS
6.4.4 OTHER TRADITIONAL WOUND CARE PRODUCTS
7 GLOBAL ACUTE WOUND CARE MARKET, BY WOUND TYPE (USD MILLIONS)
7.1 INTRODUCTION
7.2 SURGICAL & TRAUMATIC WOUNDS
7.3 BURNS AND OTHER WOUNDS
8 GLOBAL ACUTE WOUND CARE MARKET, BY END USER (USD MILLIONS)
8.1 INTRODUCTION
8.2 HOSPITALS
8.3 SPECIALTY CLINICS
8.2 HOME CARE SETTINGS
8.3 OTHER END USERS
9 GLOBAL ACUTE WOUND CARE MARKET, BY REGION (USD MILLIONS)
9.1 INTRODUCTION
9.2 NORTH AMERICA
9.2.1 US
9.2.2 CANADA
9.3 EUROPE
9.3.1 GERMANY
9.3.2 UK
9.3.3 FRANCE
9.3.4 ITALY
9.3.5 SPAIN
9.3.6 RUSSIA
9.3.7 REST OF EUROPE
9.4 ASIA PACIFIC
9.4.1 CHINA
9.4.2 JAPAN
9.4.3 INDIA
9.4.3 AUSTRALIA
9.4.3 SOUTH KOREA
9.4.4 REST OF ASIA PACIFIC
9.5 LATIN AMERICA
9.5.1 BRAZIL
9.5.2 MEXICO
9.5.2 REST OF LATIN AMERICA
9.6 MIDDLE EAST & AFRICA
10 COMPETITIVE LANDSCAPE
10.1 OVERVIEW
10.2 KEY PLAYER STRATEGIES/RIGHT TO WIN
10.3 REVENUE SHARE ANALYSIS OF THE TOP MARKET PLAYERS
10.4 MARKET SHARE ANALYSIS
10.5 COMPANY EVALUATION QUADRANT
10.6 COMPANY EVALUATION QUADRANT FOR STARTUPS/SMES (2021)
10.7 COMPETITIVE BENCHMARKING
10.8 COMPETITIVE SCENARIO
11 COMPANY PROFILES
11.1 KEY PLAYERS
(Business Overview, Products and Services Offered, Recent Developments, MnM View, Key strengths/Right to Win, Strategic Choices Made, and Weaknesses and Competitive Threats)*
11.1.1 3M
11.1.2 COLOPLAST A/S
11.1.3 MEDTRONIC
11.1.4 SMITH & NEPHEW
11.1.5 CONVATEC GROUP PLC
11.1.6 MEDLINE INDUSTRIES
11.1.7 INTEGRA LIFESCIENCES
11.1.8 JOHNSON & JOHNSON
11.1.9 MOLNLYCKE HEALTH CARE AB
11.1.10 BAXTER INTERNATIONAL
11.1.11 B. BRAUN
11.1.12 PAUL HARTMANN AG
*Details on Business Overview, Products and Services Offered, Recent Developments, MnM View, Key strengths/Right to Win, Strategic Choices Made, and Weaknesses and Competitive Threats might not be captured in case of unlisted companies.
12 APPENDIX
12.1 INDUSTRY INSIGHTS
12.2 DISCUSSION GUIDE
12.3 KNOWLEDGE STORE: MARKETSANDMARKETS’SUBSCRIPTION PORTAL
12.4 AVAILABLE CUSTOMIZATIONS
12.5 RELATED REPORTS
12.6 AUTHOR DETAILS
Growth opportunities and latent adjacency in Acute Wound Care Market